webinar register page

Webinar banner
Reperfusion Therapy for STEMI: A Case for the Pharmacoinvasive Approach Even in the USA
This presentation will focus upon the impact of early reperfusion on infarct size and outcomes with the emphasis on a systems approach in communities which do not have a PCI-capable catheterization laboratory and consequently rely on rapid transport to a referral hospital with the requisite facilities. The advantages and disadvantages of thrombolysis followed by transport (the drip and ship or pharmacoinvasive approach) will be discussed as will be the barriers to optimizing this therapeutic strategy.
• Emphasize the relationship between “time and muscle”
• Identify the rationale and the pitfalls of a system approach to reperfusion therapy in the community
• Identify situations in which a pharmacoinvasive approach may be superior to Primary PCI

Mar 12, 2021 11:00 AM in Central Time (US and Canada)

* Required information

By registering, I agree to the Privacy Statement and Terms of Service.